Saliba Burns Institute-Dr. Michael Saliba

Dr. Sulk Joon Oh, MD, Fellow College of Surgeons, Plastic Surgeon, Head of Plastic Surgery Department, Hallym Sacred Heart Hospital, Seoul, S. Korea: “We (at Hallym) have used heparin on over 400 patients (in 10 months) topically only with surgical grafting as needed and necessary.”

SBI’s goal is to affordably improve burn care, and to"put an end to burn pain and scars."
a 501C3 Public Benefit Corporation
PUT AN END TO BURN PAIN AND SCARS

Download Quicktime Video
Overview video to see and hear why this amazing treatment is
successfully being used in 15 countries worldwide.

Home About the
Institute Science of Heparin Treatment Heparin FAQs Treatment
Protocol Faculty & Presenters Articles Brochure Bibliography Contact SBI

Dr. Michael Saliba What Doctors Have to Say For Doctors
Only Heparin in Thermal Disasters Heparin Burn Meetings Case
Studies
(Pictures) Benefits Summary for Patients and Relatives Reduced Costs Using Heparin How Heparin Works
Heparin Results History of Heparin Use in Burns

Dr. Michael Saliba, M.D.

CURRICULUM VITAE

MICHAEL J. SALIBA, JR., MD. FAAFP.

7660 Fay Avenue, Suite H-350, La Jolla, CA 92037 USA

Voice & Fax: (858) 454 2686 e-mail: salibamd@msn.com

Birthplace: Trinidad Colorado, USA. June 26, 1929.

Married 44 years. Wife: Lee Saliba. One daughter and one grandson.

Education: San Diego High School; San Diego State University, BA, 1951; University of Southern California School of Medicine, MD, 1955; San Diego County General Hospital, Internship, 1956; Los Angeles Childrens Hospital Pediatric Residency, 1956-7. Charter Member Diplomate Fellow of American Academy of Family Practice, FAFP, 1983 to 1993.

Professional Activities: Private Medical Practice, 1957 – 1998. General and Family Medicine Specialty. Retired January 1998. Active Medical Research 1963- present, in clinical practice and laboratories, and in the US Naval Hospital, Mercy Hospital, Sharp Memorial Hospital, University of California San Diego.

Research Interest: Thermal injuries, myocardial infarctions, and difficult to heal wounds using heparin administered parenterally, topically, and by inhalation. Listings of Dr. Saliba’s: (1) Publications; (2) Presentations at Burn and Cardiac National and International Meetings; (3) Countries where research was introduced and is being used, and International Burn Meetings heorganized are found printed his C-V listings below.

Memberships: San Diego County Medical Association; California State Medical Association, American Medical Association (Inactive).

American Burn Association; International Society for Burn Injury (Active).

Clinical Instructor. School of Medicine, University of California, San Diego, California.

Current Professional Position: President and CEO, SALIBA BURNS INSTITUTE. La Jolla, CA 92037 USA.

The Saliba Burns Institute (SBI) is a burn research and education non-profit, public benefit, 501.c.3 approved, corporation dedicated to improving burn treatment. The goal of SBI is to conduct active burn research; and to education the public and doctors in the use of the medicine heparin in the treatment of burns. Through SBI educational activities, worldwide, heparin is now used by burn therapists in the United States, India, Russia, Bulgaria, El Salvador, Brazil, Mexico, Haiti, and Canada.

CURRICULUM VITAE LISTINGS FOR MJ SALIBA JR, MD

Publications

1. Saliba MJ Jr. Heparin in the treatment of burns. JAMA. 1967;200:650.

2. Saliba MJ Jr. Heparin efficacy in burns. II. Human thermal burn treatment with large doses of topical and parenteral heparin. Aerospace Medicine. 1970;41:1302-1306.

3. Saliba MJ Jr. Heparin efficacy in burns. I. significant early modification of experimental third-degree guinea-pig burn and ancillary findings. A double blind study. Aerospace Med 1970;41:179-187.

4. Saliba MJ Jr, Dempsey WC, and Kruggel JL. Large burns in humans, treatment with heparin. JAMA. 1973;225:261-269.

5. Saliba MJ Jr. Heparin, nature's own burn remedy? Emergency Medicine. 1973;106:111-116.

6. Saliba MJ Jr and Saliba RJ. Heparin in burns: dose related and dose dependent effects. Thrombos Diasthes Haemorrh (Stuttig). 1974;33:113-123.

7. Saliba MJ, Covell JM, and Bloor CM. Effects of heparin in large doses on the extent of myocardial ischemia after acute coronary occlusion in the dog. Am J Cardiology 1976;37:599-604.

8. Saliba MJ, Kuzman WJ, and Miller M. Effects of heparin in anticoagulant doses on the ecg and cardiac enzymes in patients with acute myocardial infarctions. Am J Cardiology. 1976;37:604-607.

9. Saliba MJ Jr: The effects and uses of heparin in the care of burns that improves treatment and enhances the quality of life. Acta Chirurgiae Plasticae 1997;39:13-16.

10. Proceedings: EFFECTS OF HEPARIN IN THE TREATMENT OF BURNS: INTERNATIONAL MEETING. Feb 24-27 1994. San Diego CA USA. Editor: Dr Saliba. Saliba MJ Jr, et al, USA, p3-8,15-68.

11. Glucosaminoglycans In Burns: Multi-Center Update: 10^th CONGRESS OF INTERNATIONAL SOCIETY FOR BURN INJURIES, Jerusalem, Israel, Nov 1-5, 1998: Abstracts of presentations: Saliba, MJ Jr., La a, CA USA.

12. Saliba MJ Jr. Heparin use in burns and protocol. HEPARIN EFFECTS IN BURNS INTERNATIONAL SYMPOSIUM. March 13, 2000. Las Vegas, Nevada. USA. Editor: Saliba. In Syllabus: pp3-15.

Reprints by e-mail: salibamd@msn.com Reprints by Fax: USA + 858 454 2686

13. Proceedings: HEPARIN EFFECTS IN BURNS INTERNATIONAL MEETING II. June 28-30, 2000. San Salvador, El Salvador. Presentations of researchers from India, Russia, Bulgaria, Brazil, El Salvador, Mexico, and USA. Editor Dr Saliba.

14. Saliba MJ. Heparin in the treatment of burns. a review. BURNS Journal of International Society for Burn Injuries. 2001;27:349-358.

15. Reyes AE, Astiazaran JA, Lopez JD, Chavez CC, Jaramilla SM, and Saliba MJ. Burns treated with and without heparin: controlled use in a thermal disaster. ANNALS OF BURNS AND FIRE DISASTERS J of Mediterranean Burn Council. 2001;14(4):183-191.

16. Zayas GA, Bonillo MA, and Saliba MJ. Heparin reduced mortality and sepsis in severely burned children. Completed manuscript submitted for publication.

17. - 40 +. Additional publications: In Proceedings of National and International Burn or Cardiology Meetings, Symposiums, and Congresses.

PRESENTATIONS OF MEDICAL RESEARCH

Cities and countries where medical research was presented: San Francisco CA, Las Vegas, NE, San Diego CA, San Antonio TX, New Orleans LA, New York NY; London, England; Munich, Germany; Basel, Switzerland; Florence, Rome and Milan, Italy; Athens, Greece; Istanbul, Turkey; Jerusalem, Israel; Prague, Czech Republic; St Petersburg and Moscow, Russia; Caracas, Venezuela; Kyoto, Japan; Tijuana, Mexico; and San Salvador, El Salvador;

COUNTRIES USING RESEARCH

Countries currently using heparin administered topically and parenterally in burns: USA, India, Russia, Bulgaria, Brazil, El Salvador, Mexico, Haiti, and Canada. Four other countries initiating use now.

SPONSOR AND ORGANIZER OF INTERNATIONAL MEETINGS

Heparin Effects In Burns International Meeting, Feb 27-29, 1994, San Diego CA with UCSD.

Heparin In Burns International Symposium, Mar 13, 2000, La Vegas. NV.

Heparin In Burns International Meeting II, June 28-30, 2000, San Salvador, El Salvador.

CURRICULUM VITAE

MICHAEL J. SALIBA, JR., MD. FAAFP.

7660 Fay Avenue, Suite H-350, La Jolla, CA 92037 USA

Voice & Fax: (858) 454 2686 e-mail: salibamd@msn.com

Birthplace: Trinidad Colorado, USA. June 26, 1929.

Married, Spouse, daughter, and grandson living.

Education: San Diego High School; San Diego State University, BA, 1951; University of Southern California School of Medicine, MD, 1955; San Diego County General Hospital, Internship, 1956; Los Angeles Childrens Hospital Pediatric Residency, 1956-7. Diplomate Fellow of American Academy of Family Practice, FAFP, 1983 to 1993.

Professional Activities: Private Medical Practice, 1957 – 1998. General and Family Medicine Specialty. Retired January 1998. Active Medical Research 1963- present, in his private clinical practice and laboratory, and in the facilities of the United States Naval Hospital, Mercy Hospital, Sharp Memorial Hospital, University of California San Diego

Research Interest: Thermal injuries, myocardial infarctions, and difficult to heal wounds using heparin administered parenterally, topically, and by inhalation. Listed below are Dr. Saliba’s: (1) Publications; (2) Presentations at Burn and Cardiac National and International Meetings; (3) Countries where research was introduced and is being used; and, International Burn Meetings he organized.